Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Angus

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 22, 2015
Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantationSiddharth Sood, Craig Haifer, Lijia Yu, et al.
Journal of Gastroenterology and Hepatology|January 5, 2007
Risk factors for liver transplantation waiting list mortalityMichael A Fink, S Roger Berry, Paul J Gow, et al.
The Journal of General Virology|June 29, 2014
Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosisEu Jin Lim, Korri El Khobar, Ruth Chin, et al.
Gut|December 18, 2012
To TOE or not to TOE? That is the question in patients with portal hypertension and varicesChristopher Leung, Sern Wei Yeoh, Lucy Y Lim, et al.
Hepatology Communications|December 24, 2021
Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty LiverIndu G Rajapaksha, Lakmie S Gunarathne, Khashayar Asadi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 31, 2017
A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantationSiddharth Sood, Craig Haifer, Lijia Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2015
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in MiceKai Y Mak, Ruth Chin, Sharon C Cunningham, et al.
Gastroenterology|June 26, 2013
Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosisJosephine A Grace, Sabine Klein, Chandana B Herath, et al.
Gut|February 28, 2013
Hepatic macrophage activation predicts clinical decompensation in chronic liver diseaseAnthony Rode, Amanda Nicoll, Holger Jon Møller, et al.
Plos One|September 26, 2015
Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver CirrhosisSabine Klein, Chandana B Herath, Robert Schierwagen, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 22, 2015
Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantationSiddharth Sood, Craig Haifer, Lijia Yu, et al.
Journal of Gastroenterology and Hepatology|January 5, 2007
Risk factors for liver transplantation waiting list mortalityMichael A Fink, S Roger Berry, Paul J Gow, et al.
The Journal of General Virology|June 29, 2014
Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosisEu Jin Lim, Korri El Khobar, Ruth Chin, et al.
Gut|December 18, 2012
To TOE or not to TOE? That is the question in patients with portal hypertension and varicesChristopher Leung, Sern Wei Yeoh, Lucy Y Lim, et al.
Hepatology Communications|December 24, 2021
Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty LiverIndu G Rajapaksha, Lakmie S Gunarathne, Khashayar Asadi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 31, 2017
A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantationSiddharth Sood, Craig Haifer, Lijia Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2015
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in MiceKai Y Mak, Ruth Chin, Sharon C Cunningham, et al.
Gastroenterology|June 26, 2013
Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosisJosephine A Grace, Sabine Klein, Chandana B Herath, et al.
Gut|February 28, 2013
Hepatic macrophage activation predicts clinical decompensation in chronic liver diseaseAnthony Rode, Amanda Nicoll, Holger Jon Møller, et al.
Plos One|September 26, 2015
Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver CirrhosisSabine Klein, Chandana B Herath, Robert Schierwagen, et al.
Pageof 12